{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:35Z","timestamp":1790109935744,"version":"4.0.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1053\/sarh.2001.25482","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T23:46:10Z","timestamp":1030232770000},"page":"21-32","source":"Crossref","is-referenced-by-count":79,"title":["Bromocriptine in rheumatic and autoimmune diseases"],"prefix":"10.1053","volume":"31","author":[{"given":"Robert W.","family":"McMurray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/sarh.2001.25482_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0049-0172(91)90028-X","article-title":"Prolactin, immunoregulation, and autoimmune diseases","volume":"20","author":"Jara","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0897.1991.tb00708.x","article-title":"The possible role of prolactin in autoimmunity","volume":"26","author":"Buskila","year":"1991","journal-title":"Am J Reprod Immunol"},{"key":"10.1053\/sarh.2001.25482_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/096120339300200201","article-title":"Prolactin: an immune-stimulating peptide that regulates other immune-modulating hormones","volume":"2","author":"Walker","year":"1993","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9343(93)90360-2","article-title":"Prolactin and immunomodulation","volume":"95","author":"Reber","year":"1993","journal-title":"Am J Med"},{"key":"10.1053\/sarh.2001.25482_bib5","first-page":"278","article-title":"Prolactin, a link between the neuroendocrine and immune systems. Role in the pathogenesis of rheumatic diseases [in French]","volume":"61","author":"Gutierez","year":"1994","journal-title":"Rev Rheum Ed Fr"},{"key":"10.1053\/sarh.2001.25482_bib6","first-page":"23","article-title":"Prolactin, bromocriptine, and autoimmune diseases","volume":"32","author":"Buskila","year":"1996","journal-title":"Isr J Med Sci."},{"key":"10.1053\/sarh.2001.25482_bib7","first-page":"128","article-title":"Hyperprolactinemia and autoimmunity","volume":"43","author":"Compan-Gonzalez","year":"1996","journal-title":"Rev Allerg Mex"},{"key":"10.1053\/sarh.2001.25482_bib8","first-page":"116","article-title":"Prolactin as an immunomodulator","volume":"44","author":"Leanos Miranda","year":"1997","journal-title":"Rev Allerg Mex"},{"key":"10.1053\/sarh.2001.25482_bib9","unstructured":"McMurray RW. Estrogen, prolactin, and autoimmunity. Int J Immunopharmacol (in press)."},{"key":"10.1053\/sarh.2001.25482_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM197801262980408","article-title":"Prolactin","volume":"298","author":"Frantz","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.25482_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/cs0650457","article-title":"Regulation of prolactin secretion by oestrogens: physiological and pathological significance","volume":"65","author":"Franks","year":"1983","journal-title":"Clin Sci"},{"key":"10.1053\/sarh.2001.25482_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000097335","article-title":"Action of pituitary and lymphocyte prolactin","volume":"4","author":"Matera","year":"1997","journal-title":"Neuroimmunomodulation"},{"key":"10.1053\/sarh.2001.25482_bib13","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1073\/pnas.89.16.7713","article-title":"Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation","volume":"89","author":"Sabharwal","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sarh.2001.25482_bib14","first-page":"733","year":"1992"},{"key":"10.1053\/sarh.2001.25482_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-2007-1003341","article-title":"Incidence and characteristics of microprolactinomas (3-5 mm) in 4199 women assayed for prolactin","volume":"24","author":"Batrinos","year":"1992","journal-title":"Horm Metab Res"},{"key":"10.1053\/sarh.2001.25482_bib16","first-page":"159","article-title":"Epidemiology of pituitary tumors","author":"Ambrosi","year":"1991"},{"key":"10.1053\/sarh.2001.25482_bib17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/eji.1830101212","article-title":"Hormonal regulation of the expression of Ia antigens on mammary gland epithelium","volume":"10","author":"Klareskog","year":"1980","journal-title":"Eur J Immunol"},{"key":"10.1053\/sarh.2001.25482_bib18","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1073\/pnas.75.6.2928","article-title":"Hormonal induction of the secretory immune system in the mammary gland","volume":"75","author":"Weisz-Carrington","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sarh.2001.25482_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/1043-2760(92)90044-2","article-title":"Different forms of the prolactin receptor. Insights into the mechanism of prolactin action","volume":"3","author":"Kelly","year":"1992","journal-title":"Trends Endocrinol Metab"},{"key":"10.1053\/sarh.2001.25482_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.1990.tb40475.x","article-title":"Prolactin-mediated regulation of gene transcription in lymphocytes","volume":"594","author":"Yu-Lee","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/sarh.2001.25482_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3181\/00379727-215-44111","article-title":"Molecular actions of prolactin in the immune system","volume":"215","author":"Yu-Lee","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1053\/sarh.2001.25482_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0014-5793(91)80437-8","article-title":"Structural symmetry of the extracellular domain of the cytokine\/growth hormone\/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis","volume":"282","author":"Thoreau","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1053\/sarh.2001.25482_bib23","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor super-family","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sarh.2001.25482_bib24","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.4049\/jimmunol.134.5.3027","article-title":"Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine","volume":"134","author":"Russell","year":"1985","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.25482_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM197910183011606","article-title":"Bromocriptine","volume":"301","author":"Parkes","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.25482_bib26","first-page":"1371","article-title":"Adenohypophyseal hormones and their hypothalamic releasing factors","author":"Ascoli","year":"1996"},{"key":"10.1053\/sarh.2001.25482_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2249.1994.tb07028.x","article-title":"Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro","volume":"95","author":"Morikawa","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/sarh.2001.25482_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2249.1993.tb07966.x","article-title":"Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro","volume":"93","author":"Morikawa","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/sarh.2001.25482_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/cs0690051","article-title":"Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients","volume":"69","author":"Degli Esposti","year":"1985","journal-title":"Clin Sci"},{"key":"10.1053\/sarh.2001.25482_bib30","first-page":"83","article-title":"Effect of the dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise and during insulin induced hypoglycemia","volume":"216","author":"Nilsson","year":"1978","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"10.1053\/sarh.2001.25482_bib31","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1982.03320360039028","article-title":"Surveillance of bromocriptine in pregnancy","volume":"247","author":"Turkalj","year":"1982","journal-title":"JAMA"},{"key":"10.1053\/sarh.2001.25482_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1530\/acta.0.0890530","article-title":"Immunodeficiency in hypophysectomized rats","volume":"89","author":"Nagy","year":"1978","journal-title":"Acta Endocrinol"},{"key":"10.1053\/sarh.2001.25482_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.178.1.231","article-title":"Differential effects of growth hormone and prolactin on murine T cell development and function","volume":"178","author":"Murphy","year":"1993","journal-title":"J Exp Med"},{"key":"10.1053\/sarh.2001.25482_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0162-3109(83)90023-1","article-title":"Immunomodulation by bromocriptine","volume":"6","author":"Nagy","year":"1983","journal-title":"Immunopharmacology"},{"key":"10.1053\/sarh.2001.25482_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-5728(90)90087-4","article-title":"Neuroimmunomodulation of in vivo anti-rotavirus humoral immune response","volume":"26","author":"Ijaz","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1053\/sarh.2001.25482_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-5728(89)90083-0","article-title":"Potentiation of antibody responsiveness after the transplantation of syngeneic pituitary gland","volume":"25","author":"Cross","year":"1989","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"10.1053\/sarh.2001.25482_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0303-7207(92)90180-E","article-title":"Interferon regulatory factor-1 is inducible by prolactin, interleukin-2 and concanavalin A in T cells","volume":"86","author":"Schwarz","year":"1992","journal-title":"Mol Cell Endocrinol."},{"key":"10.1053\/sarh.2001.25482_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0167-5699(93)90165-H","article-title":"Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system","volume":"14","author":"Hooghe","year":"1993","journal-title":"Immunol Today"},{"key":"10.1053\/sarh.2001.25482_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0065-2776(08)60860-3","article-title":"Prolactin, growth hormone, and insulin-like growth factor-I in the immune system","volume":"63","author":"Kooijman","year":"1996","journal-title":"Adv Immunol"},{"key":"10.1053\/sarh.2001.25482_bib40","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.87.16.6460","article-title":"Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin","volume":"87","author":"Clevenger","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/sarh.2001.25482_bib41","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1096\/fasebj.3.10.2787766","article-title":"Inhibition of lymphocyte proliferation by antibodies to prolactin","volume":"3","author":"Hartmann","year":"1989","journal-title":"FASEB J"},{"key":"10.1053\/sarh.2001.25482_bib42","first-page":"734A","article-title":"In vivo prolactin manipulation alters in vitro IL-2, IL-4, and IFN-\u03b3 mRNA levels in female B\/W mice (abstr)","volume":"39","author":"McMurray","year":"1991","journal-title":"Clin Res"},{"key":"10.1053\/sarh.2001.25482_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1191\/096120398678920352","article-title":"Differential effects of estrogen and prolactin on autoimmune disease in the NZB\/NZW F1 mouse model of systemic lupus erythematosus","volume":"7","author":"Elbourne","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib44","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.147.11.3780","article-title":"Prolactin influences autoimmune disease activity in the female B\/W mouse","volume":"147","author":"McMurray","year":"1991","journal-title":"J Immunol"},{"key":"10.1053\/sarh.2001.25482_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0753-3322(97)86909-0","article-title":"Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion","volume":"51","author":"Neidhart","year":"1997","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/sarh.2001.25482_bib46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF01798549","article-title":"Bromocriptine in patients with chronic autoimmune-associated disorders","volume":"69","author":"Schaaf","year":"1991","journal-title":"Klin Wochenschr"},{"key":"10.1053\/sarh.2001.25482_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0897.1994.tb00844.x","article-title":"Cellular and humoral immune parameters in women with pathological hyperprolactinemia before and during treatment with bromocriptine","volume":"31","author":"Lopez-Karpovitch","year":"1994","journal-title":"Am J Reprod Immunol"},{"key":"10.1053\/sarh.2001.25482_bib48","first-page":"2084","article-title":"Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus","volume":"22","author":"McMurray","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0090-1229(90)90008-E","article-title":"Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis","volume":"54","author":"Blank","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/sarh.2001.25482_bib50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.1780310717","article-title":"Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis","volume":"31","author":"Whyte","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/art.1780270612","article-title":"The influence of pituitary hormones on adjuvant arthritis","volume":"27","author":"Berczi","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2249.1991.tb05679.x","article-title":"Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis","volume":"85","author":"Mattsson","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/sarh.2001.25482_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0753-3322(99)80091-2","article-title":"Prolactin and prolactin-like polypeptides in rheumatoid arthritis","volume":"53","author":"Neidhart","year":"1999","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/sarh.2001.25482_bib54","first-page":"2077","article-title":"High serum prolactin levels in men with rheumatoid arthritis","volume":"25","author":"Mateo","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib55","first-page":"705","article-title":"Kinetics of prolactin release in rheumatoid arthritis","volume":"13","author":"Jorgensen","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/1529-0131(200005)43:5<1010::AID-ANR8>3.0.CO;2-O","article-title":"Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis","volume":"43","author":"Barrett","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib57","first-page":"1890","article-title":"Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis","volume":"26","author":"Nagafuchi","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib58","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.1780311022","article-title":"Bromocriptine and cyclosporine. A combination therapy in rheumatoid arthritis","volume":"31","author":"Dougados","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib59","first-page":"33","article-title":"Effects of bromocriptine in patients with active rheumatoid arthritis","volume":"126","author":"Figueroa","year":"1998","journal-title":"Rev Med Chil"},{"key":"10.1053\/sarh.2001.25482_bib60","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/rheumatology\/36.9.1022","article-title":"Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis","volume":"36","author":"Figueroa","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib61","first-page":"527","article-title":"Bromocriptine for refractory rheumatoid arthritis","volume":"133","author":"Mader","year":"1997","journal-title":"Harefuah"},{"key":"10.1053\/sarh.2001.25482_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00000441-199204000-00003","article-title":"Hyperprolactinemia in systemic lupus erythematosus: association with disease activity","volume":"303","author":"Jara","year":"1992","journal-title":"Am J Med Sci"},{"key":"10.1053\/sarh.2001.25482_bib63","first-page":"2064","article-title":"Prolactin in systemic lupus erythematosus","volume":"21","author":"Pauzner","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03009749609069215","article-title":"Hyperprolactinemia in systemic lupus erythematosus?","volume":"25","author":"Ostendorf","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib65","first-page":"629","article-title":"No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus","volume":"23","author":"Buskila","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib66","first-page":"476","article-title":"Elevated serum prolactin or elevated prolactin\/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases","volume":"23","author":"Neidhart","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib67","first-page":"37","article-title":"Hyperprolactinemia in systemic lupus erythematosus","volume":"59","author":"Huang","year":"1997","journal-title":"Chung Hua I Hsueh Tsa Chih (Taipei)"},{"key":"10.1053\/sarh.2001.25482_bib68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1191\/096120398678920361","article-title":"Prolactin levels in patients with systemic lupus erythematosus: a case controlled study","volume":"7","author":"Jimena","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib69","first-page":"55","article-title":"Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power","volume":"26","author":"Blanco-Favela","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib70","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/cimm.1995.1058","article-title":"Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells","volume":"162","author":"Blank","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1053\/sarh.2001.25482_bib71","first-page":"3211","article-title":"Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome","volume":"26","author":"Shoenfeld","year":"1994","journal-title":"Transplant Proc"},{"issue":"suppl","key":"10.1053\/sarh.2001.25482_bib72","first-page":"R22","article-title":"Intravenous immunoglobulin and bromocriptine in the treatment of refractory neuropsychiatric systemic lupus erythematosus","volume":"33","author":"Rabinovich","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib73","first-page":"843","article-title":"Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease","volume":"21","author":"McMurray","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib74","first-page":"479","article-title":"Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma","volume":"16","author":"Funauchi","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib75","first-page":"2084","article-title":"Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus","volume":"22","author":"McMurray","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096120339500400102","article-title":"Prolactin: a stimulator of disease activity in systemic lupus erythematosus","volume":"4","author":"Walker","year":"1995","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/096120330000900709","article-title":"Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine","volume":"9","author":"Walker","year":"2000","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib78","first-page":"783","article-title":"A comparative multicenter trial between bromocriptine and amitryptiline in the treatment of endogenous depression","volume":"32","author":"Theohar","year":"1982","journal-title":"Arzneimittelforschung"},{"key":"10.1053\/sarh.2001.25482_bib79","first-page":"68","article-title":"Psychiatric applications of bromocriptine therapy","volume":"51","author":"Sitland-Marken","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/sarh.2001.25482_bib80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(95)00666-4","article-title":"Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression","volume":"40","author":"Inoue","year":"1996","journal-title":"Biol Psychiatry."},{"key":"10.1053\/sarh.2001.25482_bib81","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/ajp.142.2.242","article-title":"Reduction of distress in hyperprolactinemia with bromocriptine","volume":"142","author":"Buckman","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1053\/sarh.2001.25482_bib82","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1191\/096120398678920334","article-title":"Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study","volume":"7","author":"Alvarez-Nemegyei","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib83","first-page":"S282","article-title":"Treatment of active systemic lupus erythematosus (SLE) with the prolactin lowering drug bromocriptine: comparison with hydroxychloroquine in a randomized, blinded one-year study","volume":"42","author":"Walker","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/096120339300200202","article-title":"Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus","volume":"2","author":"Lavalle","year":"1993","journal-title":"Lupus"},{"key":"10.1053\/sarh.2001.25482_bib85","first-page":"747","article-title":"An acute remission of Reiter's syndrome in male patients treated with bromocriptine","volume":"19","author":"Bravo","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib86","first-page":"1456","article-title":"Treatment of psoriasis arthropathica with bromocriptine","volume":"61","author":"Weber","year":"1986","journal-title":"Z Hautkr"},{"key":"10.1053\/sarh.2001.25482_bib87","first-page":"607","article-title":"Therapeutic efficacy of bromocriptine in psoriatic arthritis (two case-reports)","volume":"62","author":"Eulry","year":"1995","journal-title":"Rev Rheum Engl Ed"},{"key":"10.1053\/sarh.2001.25482_bib88","first-page":"611","article-title":"Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia","volume":"18","author":"Buskila","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib89","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0190-9622(87)80135-4","article-title":"Treatment of psoriatic arthritis with bromocriptine","volume":"16","author":"Weber","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sarh.2001.25482_bib90","first-page":"15","article-title":"Blood prolactin under the effect of protirelin in spondylarthropathies. Treatment trial of 4 cases of reactive arthritis and 2 cases of psoriatic arthritis with bromocriptine","volume":"147","author":"Eulry","year":"1996","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1053\/sarh.2001.25482_bib91","first-page":"1642","article-title":"Treatment of rheumatoid psoriasis with bromocriptine","volume":"24","author":"Eulry","year":"1995","journal-title":"Presse Med"},{"key":"10.1053\/sarh.2001.25482_bib92","first-page":"863","article-title":"Prolactin response to protirelin in reactive arthritis and ankylosing spondyloarthritis. Failure of treatment of 4 reactive arthritis with bromocriptine","volume":"61","author":"Eulry","year":"1994","journal-title":"Rev Rheum Ed Fr"},{"key":"10.1053\/sarh.2001.25482_bib93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017981","article-title":"Prolactin: does it have a role in the pathogenesis of psoriasis?","volume":"197","author":"Giasuddin","year":"1998","journal-title":"Dermatology"},{"key":"10.1053\/sarh.2001.25482_bib94","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1172\/JCI112921","article-title":"Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat","volume":"79","author":"Palestine","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1053\/sarh.2001.25482_bib95","first-page":"161","article-title":"Bromocriptine in therapy of chronic recurrent anterior uveitis","volume":"88","author":"Zierhut","year":"1991","journal-title":"Fortschr Ophthalmol"},{"key":"10.1053\/sarh.2001.25482_bib96","first-page":"368","article-title":"Basic and clinical immunology in uveitis","volume":"31","author":"Nussenblatt","year":"1987","journal-title":"Jpn J Ophthalmol"},{"key":"10.1053\/sarh.2001.25482_bib97","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9394(85)90697-X","article-title":"Endogenous iridocyclitis relieved during treatment with bromocriptine","volume":"100","author":"Hedner","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1053\/sarh.2001.25482_bib98","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0090-1229(90)90008-E","article-title":"Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis","volume":"54","author":"Blank","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/sarh.2001.25482_bib99","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0002-9394(88)90890-2","article-title":"The effect of bromocriptine on anterior uveitis","volume":"106","author":"Palestine","year":"1988","journal-title":"Am J Ophthalmol"},{"issue":"suppl A","key":"10.1053\/sarh.2001.25482_bib100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0896-8411(92)90040-W","article-title":"The expanding use of immunosuppression in the treatment of non-infectious ocular disease","volume":"5","author":"Nussenblatt","year":"1992","journal-title":"J Autoimmun"},{"issue":"suppl 4","key":"10.1053\/sarh.2001.25482_bib101","first-page":"131","article-title":"Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine","volume":"20","author":"Palestine","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1053\/sarh.2001.25482_bib102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1046443","article-title":"Bromocriptine: a new therapy concept in the treatment of chronic recurrent uveitis?","volume":"195","author":"Zierhut","year":"1989","journal-title":"Klin Monatsbl Augenheilkd."},{"key":"10.1053\/sarh.2001.25482_bib103","first-page":"483","article-title":"A case of multiple sclerosis with galactorrhea-amenorrhea syndrome","volume":"37","author":"Tanaka","year":"1997","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1053\/sarh.2001.25482_bib104","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/07435809909066142","article-title":"Prolactin secretion is increased in patients with multiple sclerosis","volume":"25","author":"Azar","year":"1999","journal-title":"Endocr Res"},{"key":"10.1053\/sarh.2001.25482_bib105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group [see comments]","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/sarh.2001.25482_bib106","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-4530(94)90003-5","article-title":"Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis","volume":"19","author":"Dijkstra","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1053\/sarh.2001.25482_bib107","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.410290514","article-title":"The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine","volume":"29","author":"Riskind","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1053\/sarh.2001.25482_bib108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/jnnp.58.2.253","article-title":"Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine","volume":"58","author":"Khan","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/sarh.2001.25482_bib109","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00002826-199410000-00011","article-title":"Bromocriptine therapy in multiple sclerosis: an open label pilot study","volume":"17","author":"Bissay","year":"1994","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/sarh.2001.25482_bib110","first-page":"1291","article-title":"The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome","volume":"26","author":"Haga","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib111","first-page":"25","article-title":"Prolactin levels in patients with systemic scleroderma","volume":"76","author":"Alekperov","year":"1998","journal-title":"Klin Med (Mosk)"},{"key":"10.1053\/sarh.2001.25482_bib112","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/rheumatology\/36.4.426","article-title":"High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis","volume":"36","author":"Straub","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib113","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02229718","article-title":"High serum level of prolactin in patients with systemic sclerosis","volume":"15","author":"Kucharz","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1053\/sarh.2001.25482_bib114","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/000331979004100504","article-title":"Effect of captopril on plasma prolactin in patients with essential hypertension","volume":"41","author":"Saito","year":"1990","journal-title":"Angiology"},{"key":"10.1053\/sarh.2001.25482_bib115","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archinte.1984.00350160083015","article-title":"Captopril in the treatment of scleroderma renal crisis","volume":"144","author":"Thurm","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1053\/sarh.2001.25482_bib116","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.410240318","article-title":"A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome","volume":"24","author":"Walters","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1053\/sarh.2001.25482_bib117","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00002060-199609000-00007","article-title":"Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue","volume":"75","author":"Bruno","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1053\/sarh.2001.25482_bib118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.48.1.101","article-title":"Continuous bromocriptine therapy in menstrual migraine","volume":"48","author":"Herzog","year":"1997","journal-title":"Neurology"},{"key":"10.1053\/sarh.2001.25482_bib119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2265.1985.tb03244.x","article-title":"Review: premenstrual syndrome","volume":"22","author":"Bancroft","year":"1985","journal-title":"Clin Endocrinol"},{"issue":"suppl","key":"10.1053\/sarh.2001.25482_bib120","first-page":"S350","article-title":"Prolactin levels in primary fibromyalgia","volume":"37","author":"Kotter","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sarh.2001.25482_bib121","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s000180050197","article-title":"Bromocriptine\/SKF38393 ameliorates islet dysfunction in the diabetic (db\/db) mouse","volume":"54","author":"Liang","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/sarh.2001.25482_bib122","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF01930467","article-title":"Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics","volume":"48","author":"Meier","year":"1992","journal-title":"Experientia"},{"key":"10.1053\/sarh.2001.25482_bib123","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0003-4975(90)90370-L","article-title":"Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation","volume":"49","author":"Carrier","year":"1990","journal-title":"Ann Thorac Surg"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017201653344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017201653344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:44:35Z","timestamp":1682124275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017201653344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0049017201653344"],"URL":"https:\/\/doi.org\/10.1053\/sarh.2001.25482","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}